經濟通串流版 ET Net IQ Streaming - 東瑞製葯 DAWNRAYS PHARMACEUTICAL (HOLDINGS) LTD.

公司資料 - 財務比率

		東瑞製葯（控股）有限公司	股票編號：	02348
		DAWNRAYS PHARMACEUTICAL (HOLDINGS) LTD.	集團網址：	http://www.dawnrays.com

盈利能力分析

	2024/12	2023/12	2022/12	2021/12	2020/12
資產回報率 (%)	14.805%	8.937%	10.212%	11.474%	9.424%
股東資金回報率 (%)	18.286%	11.862%	14.258%	15.740%	12.780%
資本運用回報率 (%)	16.353%	11.037%	13.065%	13.555%	11.062%

邊際利潤分析

毛利率 (%)	54.477%	55.729%	60.543%	58.470%	53.760%
未計利息、稅項、折舊及攤銷前利潤率 (%)	67.382%	44.646%	42.868%	44.982%	38.450%
稅前邊際利潤率 (%)	60.072%	35.969%	34.313%	37.705%	32.345%
純利率 (%)	53.281%	28.320%	28.024%	30.741%	26.178%

變現能力分析

流動比率 (X)	3.971 X	2.572 X	1.871 X	2.168 X	3.227 X
速動比率 (X)	3.415 X	2.256 X	1.612 X	1.876 X	2.714 X

財務槓桿分析

總負債 / 總資產比率 (%)	17.026%	21.074%	27.849%	28.198%	24.801%
總負債 / 股東資金比率 (%)	20.534%	26.743%	38.713%	39.555%	33.179%
非流動負債 / 股東資金比率 (%)	3.851%	3.310%	3.434%	10.274%	11.068%
利息盈利率 (倍)	177.538 X	419.662 X	1182.693 X	686.371 X	69.620 X

營運效率分析

存貨周轉率日數 (日)

89.390 Day(s)

71.794 Day(s)

63.594 Day(s)

70.406 Day(s)

76.043 Day(s)

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.